Capsida Biotherapeutics Funding & Investors
Buena Park, CA
Capsida is a biotechnology company that specializes in tackling monogenetic and sporadic CNS and non-CNS disorders.
capsida.comTotal Amount Raised: $140,000,000
Capsida Biotherapeutics Funding Rounds
Series A
$50,000,000
Series A Investors
Versant VenturesWestlake Village BioPartnersCorporate Round
$90,000,000
Corporate Round Investors
AbbVie
Funding info provided by Diffbot.